Induction chemotherapy followed by either chemoradiotherapy or bioradiotherapy for larynx preservation: The TREMPLIN randomized phase II study

Journal of Clinical Oncology

Volumn 31, Issue 7, 2013, Pages 853-859

  Lefebvre, Jean Louis ^a   Pointreau, Yoann ^c   Rolland, Frederic ^d   Alfonsi, Marc ^f   Baudoux, Alain ^t   Sire, Christian ^g   De Raucourt, Dominique ^h   Malard, Olivier ^e   Degardin, Marian ^a   Tuchais, Claude ^j   Blot, Emmanuel ^k   Rives, Michel ^l   Reyt, Emile ^m   Tourani, Jean Marc ⁿ   Geoffrois, Lionel ^o   Peyrade, Frederic ^p   Guichard, Francois ^q   Chevalier, Dominique ^b   Babin, Emmanuel ⁱ   Lang, Philippe ^r   Janot, Francois ^s   Calais, Gilles ^c   Garaud, Pascal ^c   Bardet, Etienne ^d   more..

^a CENTRE OSCAR LAMBRET   (France)

^b CENTRE HOSPITALIER   (France)

^c UNIVERSITY HOSPITAL OF TOURS   (France)

^d Institute de Cancerologie de L'Ouest René Gauducheau   (France)

^e HÔTEL DIEU   (France)

^f INSTITUT SAINTE CATHERINE   (France)

^g Centre Hospitalier de Lorient   (France)

^h CENTRE FRANÇOIS BACLESSE   (France)

ⁱ CHU CÔTE DE NACRE   (France)

^j Institut de cancérologie de l'Ouest   (France)

^k CENTRE HENRI BECQUEREL   (France)

^l INSTITUT CLAUDIUS REGAUD   (France)

^m HÔPITAL MICHALLON   (France)

ⁿ University of Poitiers   (France)

^o CENTRE ALEXIS VAUTRIN   (France)

^p Institut universitaire de la face et du cou   (France)

^q Polyclinique de Bordeaux Nord   (France)

^r PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^s INSTITUT GUSTAVE ROUSSY   (France)

^t Hospital Sainte Elisabeth   (Belgium)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CIPROFLOXACIN; CISPLATIN; DEXAMETHASONE; DOCETAXEL; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CHEMORADIOTHERAPY; CLINICAL PROTOCOL; CONTROLLED STUDY; EVIDENCE BASED PRACTICE; FEMALE; HUMAN; INDUCTION CHEMOTHERAPY; LARYNX FUNCTION PRESERVATION; LARYNX SQUAMOUS CELL CARCINOMA; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; ORGAN PRESERVATION; OVERALL SURVIVAL; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PREMEDICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALVAGE THERAPY; STATISTICAL SIGNIFICANCE; SURVIVAL TIME; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHEMORADIOTHERAPY, ADJUVANT; CISPLATIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; HYPOPHARYNGEAL NEOPLASMS; INDUCTION CHEMOTHERAPY; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; ORGAN SPARING TREATMENTS; POPULATION SURVEILLANCE; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 84875711689     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.42.3988     Document Type: Article

References (17)

1. American Society of Clinical Oncology, Pfister DG, Laurie SA, et al: American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol 24:3693- 3704, 2006. (Pubitemid 46630546)
2. [No authors listed]: Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer: The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 324:1685- 1690, 1991.
3. Richard JM, Sancho-Garnier H, Pessey JJ, et al: Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 34:224-228, 1998. (Pubitemid 28267175)
4. Lefebvre JL, Chevalier D, Luboinski B, et al: Larynx preservation in pyriform sinus cancer: Preliminary results of a European Organization for Research and Treatment of Cancer phase III trial-EORTC Head and Neck Cancer Cooperative Group. J Natl Cancer Inst 88:890-899, 1996. (Pubitemid 26230640)
5. Pignon JP, Bourhis J, Domenge C, et al: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data-MACH-NC Collaborative Group, Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 355:949-955, 2000. (Pubitemid 30148259)
6. Pointreau Y, Garaud P, Chapet S, et al: Randomized trial of induction chemotherapy with cisplatin and 5-fluorouracil with or without docetaxel for larynx preservation. J Natl Cancer Inst 101:498-506, 2009.
7. Forastiere AA, Goepfert H, Maor M, et al: Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349:2091-2098, 2003. (Pubitemid 37464533)
8. Forastiere AA, Maor M, Weber RS, et al: Long-term results of Intergroup RTOG 91-11: A phase III trial to preserve the larynx-Induction cisplatin/5-FU and radiation therapy versus concurrent cisplatin and radiation therapy versus radiation therapy. J Clin Oncol 24:284s, 2006 (suppl; abstr 5517).
9. Lefebvre JL, Rolland F, Tesselaar M, et al: Phase 3 randomized trial on larynx preservation comparing sequential vs alternating chemotherapy and radiotherapy. J Natl Cancer Inst 101:142-152, 2009.
10. Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 354:567-578, 2006. (Pubitemid 43209104)
11. Bonner JA, Harari PM, Giralt J, et al: Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol 11:21-28, 2010.
12. Lefebvre JL, Ang KK, Larynx Preservation Consensus Panel: Larynx preservation clinical trial design: Key issues and recommendations-A consensus panel summary. Int J Radiat Oncol Biol Phys 73:1293-1303, 2009.
13. Lefebvre JL, Ang KK, Larynx Preservation Consensus Panel: Larynx preservation clinical trial design: Key issues and recommendations-A consensus panel summary. Head Neck 31:429- 441, 2009.
14. Vermorken JB, Remenar E, van Herpen C, et al: Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357:1695-1704, 2007. (Pubitemid 350005151)
15. Posner MR, Hershock DM, Blajman CR, et al: Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357:1705-1715, 2007. (Pubitemid 350005152)
16. Posner MR, Norris CM, Wirth LJ, et al: Sequential therapy for locally advanced larynx and hypopharynx cancer subgroup in TAX 324: Survival, surgery, and organ preservation. Ann Oncol 20:921-927, 2009.
17. Machtay M, Moughan J, Trotti A, et al: Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis. J Clin Oncol 26:3582-3589, 2008.